Curtiss-Wright Bulls Take Charge Ahead of Q2 Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
CW heads into today's Q2 release with options sentiment having swung decisively toward the bullish side — a sharper move than the earlier preview captured.
The options shift is the clearest signal into the print. The put/call ratio has dropped further to 0.94, now running more than two standard deviations below its 20-day average of 1.25. That is the most bullishly positioned reading in the past year, a complete reversal from mid-July when the PCR was touching its 52-week high near 1.48. Investors are not hedging — they are shedding protection. The stock has recovered strongly to back it up: up 10% on the week to $748, even after a modest 1.2% dip on Wednesday.
Short interest does nothing to complicate that picture. Bears have been retreating. At roughly 1.9% of free float, short interest is low and flat — down 5.6% over the past month. Borrow conditions remain almost frictionless: cost to borrow has ticked up about 16% on the week but remains just 0.48%, and availability is extraordinarily loose at over 6,700% of short interest. There is no squeeze dynamic here, and no sign of mounting conviction on the short side.
The debate heading into the print is essentially about execution against a high bar. Bulls point to the momentum from Q1 — 14% EPS growth to $3.40, Defense Electronics revenue up 17.5% year-over-year, and guidance raised to 10-11% full-year revenue growth. The analyst community has been steadily ratcheting targets higher throughout 2026, with the consensus mean now at $822 — about 10% above the current price — though the most recent coverage from Stifel (July 20) and Citigroup (July 1) sits at Hold/Neutral ratings. Bears are focused on order timing risk: $50 million in Defense Electronics orders slipped out of Q3 2025 due to continuing resolution uncertainty, and percentage-of-completion accounting means revenue recognition can compress if contract milestones shift. Valuation leaves little room for disappointment — the stock trades at roughly 44x trailing earnings and 30.6x EV/EBITDA.
The Q2 print is therefore less a test of whether Curtiss-Wright is growing and more a test of whether the order book is rebuilding cleanly enough to justify the multiple and the bullish repositioning that has defined the past two weeks of trading.
Stocks in this article
See the live data behind this article on ORTEX.
Open CW on ORTEX →How this article was generated
- Generated
- 6 Aug 2026, 04:05
- Data as of
- 6 Aug 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.